Kezar Life Sciences, Inc. (KZR)
7.33
-0.04
(-0.54%)
USD |
NASDAQ |
Apr 17, 16:00
7.34
+0.01
(+0.14%)
After-Hours: 20:00
Kezar Life Sciences Shareholders Equity (Quarterly) : 70.07M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Apellis Pharmaceuticals, Inc. | 370.15M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 203.13M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 76.65M |
| Total Liabilities (Quarterly) | 6.574M |
| Debt to Equity Ratio | 0.0332 |
| Current Ratio | 11.52 |
| Net Debt Paydown Yield | 6.33% |